FDA clears Live Tissue Connect's VAD system
This article was originally published in Clinica
Live Tissue Connect's VAD system has received US FDA 510(k) clearance. The system, intended for use in open general surgical and gynaecological procedures, comprises the VAD.400 bipolar electrosurgical generator and two disposable sealing instruments. It employs radiofrequency technology to bond tissue in live organs, and can reconnect soft tissue through fusion, unlike conventional wound closing devices like sutures and staples. VAD.400 can be used on veins and arteries with a diameter of up to 7mm and ducts up to 2mm in diameter. LTC, a subsidiary of Corpus Christi, Texas-based CSMG Technologies, CE marked the system for sale in Europe in December 2007 (see Clinica No 1285, p 18).